Cargando…
Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
Glioblastoma multiforme (GBM) is the most malignant primary brain cancer affecting adults. Therapeutic options for GBM have remained the same for over a decade with no significant improvement. Many therapies that are successful in culture have failed in patients, likely due to the complex microenvir...
Autores principales: | Kerstetter-Fogle, Amber E., Harris, Peggy L. R., Brady-Kalnay, Susann M., Sloan, Andrew E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403971/ https://www.ncbi.nlm.nih.gov/pubmed/32698368 http://dx.doi.org/10.3390/ijms21145113 |
Ejemplares similares
-
Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy
por: Kerstetter-Fogle, Amber, et al.
Publicado: (2019) -
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments
por: Soler, David C., et al.
Publicado: (2021) -
Proteins inform survival-based differences in patients with glioblastoma
por: Stetson, L C, et al.
Publicado: (2020) -
Detection of Tumor-Specific PTPmu in Gynecological Cancer and Patient Derived Xenografts
por: Vincent, Jason, et al.
Publicado: (2021) -
Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesis
por: Sloan, Anthony R, et al.
Publicado: (2022)